NASDAQ: SMLRSemler Scientific Inc Stock
$25.73+0.00 (+0%)
Updated Mar 24, 2023
SMLR Price
$25.73
Fair Value Price
$28.64
Market Cap
$176.11M
52 Week Low
$19.12
52 Week High
$52.34
P/E
12.08x
P/B
3.16x
P/S
3.92x
PEG
0.61x
Dividend Yield
N/A
Revenue
$56.69M
Earnings
$14.33M
Gross Margin
92.5%
Operating Margin
31.21%
Profit Margin
25.3%
Debt to Equity
0.13
Operating Cash Flow
$17M
Beta
0.88
Next Earnings
May 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A
SMLR Overview
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Zen Score
–
Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SMLR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SMLR ($25.73) is undervalued by 10.15% relative to our estimate of its Fair Value price of $28.64 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SMLR ($25.73) is not significantly undervalued (10.15%) relative to our estimate of its Fair Value price of $28.64 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SMLR ($25.73) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SMLR due diligence checks available for Premium users.
Be the first to know about important SMLR news, forecast changes, insider trades & much more!
SMLR News
Valuation
SMLR fair value
Fair Value of SMLR stock based on Discounted Cash Flow (DCF)
Price
$25.73
Fair Value
$28.64
Undervalued by
10.15%
SMLR ($25.73) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SMLR ($25.73) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SMLR ($25.73) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SMLR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
12.08x
Industry
87.96x
Market
21.37x
SMLR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SMLR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SMLR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.16x
Industry
3.77x
SMLR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SMLR price to earnings growth (PEG)
For valuing profitable companies with growth potential
SMLR is good value based... subscribe to Premium to read more.
PEG Value Valuation
SMLR's financial health
Profit margin
Revenue
$13.8M
Net Income
$3.2M
Profit Margin
23.3%
SMLR's Earnings (EBIT) of $17.69M... subscribe to Premium to read more.
Interest Coverage Financials
SMLR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$62.7M
Liabilities
$7.0M
Debt to equity
0.13
SMLR's short-term assets ($48.91M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SMLR's short-term assets ($48.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SMLR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SMLR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$1.7M
Investing
-$24.3M
Financing
$75.0k
SMLR's operating cash flow ($17.46M)... subscribe to Premium to read more.
Debt Coverage Financials
SMLR vs Medical Device Stocks
Semler Scientific Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.